Bio-Techne
- Market cap
- 11.37B
- P/E (TTM)i
- 62.53
- P/Bi
- 5.39
- EPSi
- 1.16
- Div yieldi
- 0.44%
- 52W posi
- 99%
Anonymous reader poll. Unscientific, not investment advice.
About Bio-Techne
Bio-Techne Corp. is a global life sciences company providing innovative tools and bioactive reagents for research and clinical diagnostic communities. Its products assist scientific investigations into biological processes and the nature and progress of specific diseases. It operates through the Protein Sciences, and Diagnostics and Spatial Biology segments. The Protein Sciences segment develops and manufactures purified proteins, and reagent solutions. The Diagnostics and Spatial Biology segment develops and manufactures diagnostic products. The company was founded in 1976 and is headquartered in Minneapolis, MN.
- Founded
- 1976
- CEO
- Mr. Kim Kelderman
- Employees
- 3,000
- Headquarters
- Minneapolis, Minnesota, United States of America
- Fiscal year end
- 06-30
- Website
- bio-techne.com
Company profile
- Exchange
- US
- Symbol
- TECH
- Market-cap rank
- #1365
- Listing date
- 1970-01-01
- Market cap
- 11.37B
- Float cap
- 11.33B
- Shares out
- 156.82M
- Float shares
- 156.15M
Sectors & themes
Quote time 2026-10-08 07:40:17 · For reference only, not investment advice and not tailored to your situation.